Benefits
Burdens
Citations
1. Kass NE. An ethics framework for public health. Am J Public Health 2001; 91:1776-1782. 2. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for breast cancer: an update for the U.S. preventive services task force. Ann Intern Med 2009; 151(10):7 27-737. 3. Smith RA, Saslow D, Sawyer KA, Burke W, Costanza ME, Evans WP, Foster RS, Hendrick E, Eyre HJ, Sener S. American cancer society guidelines for breast cancer screening: update 2003. CA Cancer J Clin 2003; 53:141-169. 4. ACOG practice panel. Breast cancer Screening. Obstegrics & Gynecology 2011; 118(2):372-382. 5. Lebovic GS, Hollingsworth A, Feig SA. Risk assessment, screening and prevention of breast cancer: A look at cost-effectiveness. The Breast 2010; 19:260-267. 6. Gross CP, Long JB, Ross JS, Abu-Khalaf MM, Wang R, Killelea BK, Gold HT, Chagpar AB, Ma X. The cost of breast cancer screening in the medicare population. JAMA Intern Med 2013; 173(3):220-226. 7. Pharoah PDP, Sewell B, Fitzsimmons D, Bennett HS, Pashayan N. Cost effectiveness of the NHS breast screening programme: life table model. BMJ 2013; 346:f2618. 8. Gtzsche PC, Jrgensen KJ. Screening for breast cancer with mammography. Cochrane library; 2013: Issue 6. 9. Bleyer A and Welch HG. Effects of three decades of screening mammography on breast-cancer incidence. NEJM 2012; 367:21. 10. Osterlie W, Solbjor M, Skolbekken J-A, Hofvind S, Saetnan AR, Forsmo S. Challenges of informed choice in organized screening. J Med Ethics 2008; 34:e5. 11. Pace LE, He Y, Keating NL. Trends in mammography screening rates after publication of the 2009 US preventive services task for recommendations. Cancer 2013; 119:2518-23.